Ongoing investigations into this medication are showcasing promising outcomes regarding body composition . Initially developed for managing type 2 diabetes , this GLP-1 receptor agonist has proven https://bookmarkbells.com/story21559586/semaglutide-research-exploring-emerging-body-shaping-potential